MORN3

gene
On this page

Summary

MORN3 (MORN repeat containing 3, HGNC:29807) is a protein-coding gene on chromosome 12q24.31, encoding MORN repeat-containing protein 3 (Q6PF18). Assembles a suppression complex (suppresome) by tethering SIRT1 and MDM2 to regulate composite modifications of p53/TP53.

Enables protein-macromolecule adaptor activity. Involved in negative regulation of signal transduction by p53 class mediator. Located in nucleus.

Source: NCBI Gene 283385 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 63 total
  • MANE Select transcript: NM_173855

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29807
Approved symbolMORN3
NameMORN repeat containing 3
Location12q24.31
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000139714
Ensembl biotypeprotein_coding
Entrez283385

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 6 protein_coding, 2 nonsense_mediated_decay

ENST00000355329, ENST00000392462, ENST00000542364, ENST00000879182, ENST00000879183, ENST00000879184, ENST00000931069, ENST00000944504

RefSeq mRNA: 2 — MANE Select: NM_173855 NM_001363685, NM_173855

CCDS: CCDS31917

Canonical transcript exons

ENST00000355329 — 6 exons

ExonStartEnd
ENSE00000939814121654274121654433
ENSE00001036442121659191121659348
ENSE00001411960121669339121669654
ENSE00001412791121653075121653259
ENSE00002294122121648742121651644
ENSE00003534006121652728121652808

Expression profiles

Bgee: expression breadth ubiquitous, 164 present calls, max score 97.59.

FANTOM5 (CAGE): breadth broad, TPM avg 2.1514 / max 91.1192, expressed in 579 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
1337501.2202476
1337490.6705117
1337480.111321
1337470.086526
1337460.040720
1337450.02229

Top tissues by expression

239 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001997.59gold quality
left testisUBERON:000453393.49gold quality
right testisUBERON:000453493.05gold quality
testisUBERON:000047389.70gold quality
bronchial epithelial cellCL:000232889.38gold quality
bronchusUBERON:000218588.12gold quality
right uterine tubeUBERON:000130284.13gold quality
olfactory segment of nasal mucosaUBERON:000538682.10gold quality
adult organismUBERON:000702381.75gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451179.60gold quality
buccal mucosa cellCL:000233679.47gold quality
upper arm skinUBERON:000426378.81gold quality
tendon of biceps brachiiUBERON:000818877.15silver quality
mucosa of paranasal sinusUBERON:000503076.04silver quality
cortical plateUBERON:000534375.48gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047375.20gold quality
epithelial cell of pancreasCL:000008374.64gold quality
cardiac muscle of right atriumUBERON:000337974.05gold quality
left ventricle myocardiumUBERON:000656673.88gold quality
prefrontal cortexUBERON:000045173.83gold quality
epithelium of nasopharynxUBERON:000195173.63gold quality
nasal cavity mucosaUBERON:000182673.48gold quality
stromal cell of endometriumCL:000225571.71gold quality
granulocyteCL:000009471.69gold quality
myocardiumUBERON:000234971.47gold quality
nasal cavity epitheliumUBERON:000538471.02gold quality
placentaUBERON:000198770.55gold quality
ventricular zoneUBERON:000305370.37gold quality
quadriceps femorisUBERON:000137769.86gold quality
vastus lateralisUBERON:000137969.68gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.28

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

11 targeting MORN3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3667-3P99.9967.171636
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-391999.8769.452489
HSA-MIR-1255A99.7468.09744
HSA-MIR-1255B-5P99.7468.16741
HSA-MIR-6731-5P99.2867.422375
HSA-MIR-808599.2867.562362
HSA-MIR-66199.0965.942062
HSA-MIR-429798.7766.952013
HSA-MIR-31-5P98.5868.351239
HSA-MIR-1255B-2-3P97.8067.04880

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriomorn3ENSDARG00000021697
mus_musculusMorn3ENSMUSG00000029477
rattus_norvegicusMorn3ENSRNOG00000045574
drosophila_melanogasterCG30429FBGN0050429

Paralogs (7): MORN1 (ENSG00000116151), SETD7 (ENSG00000145391), RSPH10B (ENSG00000155026), RSPH1 (ENSG00000160188), RSPH10B2 (ENSG00000169402), ALS2CL (ENSG00000178038), MORN2 (ENSG00000188010)

Protein

Protein identifiers

MORN repeat-containing protein 3Q6PF18 (reviewed: Q6PF18)

All UniProt accessions (1): Q6PF18

UniProt curated annotations — full annotation on UniProt →

Function. Assembles a suppression complex (suppresome) by tethering SIRT1 and MDM2 to regulate composite modifications of p53/TP53. Confers both deacetylation-mediated functional inactivation, by SIRT1, and ubiquitination-dependent degradation, by MDM2, of p53/TP53, promoting a proliferative and cell survival behaviors. May play a role in the regulation of spermatogenesis.

Subunit / interactions. Interacts with MEIG1. Interacts with TP53, MDM2 and SIRT1; the interactions mediate post-transcriptional modifications of TP53 by MDM2 and SIRT1.

Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome.

Isoforms (2)

UniProt IDNamesCanonical?
Q6PF18-11yes
Q6PF18-22

RefSeq proteins (2): NP_001350614, NP_776254* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003409MORNRepeat
IPR052472MORN3Family

Pfam: PF02493

UniProt features (14 total): repeat 7, region of interest 3, splice variant 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
8J07ELECTRON MICROSCOPY4.1

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6PF18-F192.560.79

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 46 (showing top): GOCC_SECRETORY_GRANULE, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, GOCC_SECRETORY_VESICLE, GOCC_ACROSOMAL_VESICLE, chr12q24, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MARTENS_BOUND_BY_PML_RARA_FUSION, SRC_UP.V1_UP, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP, MIR1255A_MIR1255B_5P, GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP

GO Biological Process (2): negative regulation of signal transduction by p53 class mediator (GO:1901797), signal transduction by p53 class mediator (GO:0072331)

GO Molecular Function (2): protein-macromolecule adaptor activity (GO:0030674), protein binding (GO:0005515)

GO Cellular Component (3): acrosomal vesicle (GO:0001669), nucleus (GO:0005634), cytoplasmic vesicle (GO:0031410)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
signal transduction by p53 class mediator1
regulation of signal transduction by p53 class mediator1
negative regulation of intracellular signal transduction1
intracellular signal transduction1
protein binding1
molecular adaptor activity1
binding1
secretory granule1
intracellular membrane-bounded organelle1
cytoplasm1
intracellular vesicle1

Protein interactions and networks

STRING

752 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MORN3MORN5Q5VZ52709
MORN3PACRGQ96M98575
MORN3RIMBP3Q9UFD9575
MORN3HOOK1Q9UJC3538
MORN3KIF3BO15066493
MORN3LRGUKQ96M69488
MORN3SCP2P22307468
MORN3EEF1E1O43324456
MORN3CCNI2Q6ZMN8456
MORN3TCFL5Q9UL49450
MORN3LNPEPQ9UIQ6449
MORN3CCDC148Q8NFR7449
MORN3RSPH3Q86UC2446
MORN3NOC2LQ9Y3T9442
MORN3TMEM120BA0PK00433

IntAct

240 interactions, top by confidence:

ABTypeScore
GOLGA2MORN3psi-mi:“MI:0915”(physical association)0.790
TRAF1MORN3psi-mi:“MI:0915”(physical association)0.790
MORN3GOLGA2psi-mi:“MI:0915”(physical association)0.790
MORN3TRAF1psi-mi:“MI:0915”(physical association)0.790
MORN3RSPH1psi-mi:“MI:0915”(physical association)0.780
IKZF3MORN3psi-mi:“MI:0915”(physical association)0.780
RSPH1MORN3psi-mi:“MI:0915”(physical association)0.780
MORN3IKZF3psi-mi:“MI:0915”(physical association)0.780
MORN3MAGEA6psi-mi:“MI:0915”(physical association)0.720
TRAF2MORN3psi-mi:“MI:0915”(physical association)0.720

BioGRID (79): MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid)

ESM2 similar proteins: B6CZ17, B6CZ18, O00423, P10830, P53671, Q05BC3, Q08CH7, Q09537, Q15326, Q1XHL7, Q21029, Q28FE4, Q32KM6, Q32KU3, Q32LL6, Q49HM9, Q4R3N2, Q4R842, Q4V8C3, Q4VBJ9, Q502X0, Q569C2, Q5PPV3, Q5TYQ3, Q5VZ52, Q5ZIJ9, Q622Z7, Q63651, Q641X6, Q6GNY1, Q6IND7, Q6PF18, Q6VTH5, Q7DMA9, Q7Z0G7, Q804S5, Q80SY4, Q86YT6, Q8C5T4, Q8K4M9

Diamond homologs: Q32KM6, Q4R842, Q5PPV3, Q6PF18, Q8C5T4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

63 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance44
Likely benign3
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

670 predictions. Top by Δscore:

VariantEffectΔscore
12:121652744:T:TAdonor_gain1.0000
12:121654267:CACT:Cdonor_loss1.0000
12:121654270:TCA:Tdonor_loss1.0000
12:121654271:CAC:Cdonor_loss1.0000
12:121654272:A:ACdonor_gain1.0000
12:121654272:A:Tdonor_loss1.0000
12:121654273:C:Adonor_loss1.0000
12:121654273:C:CAdonor_gain1.0000
12:121654273:CT:Cdonor_gain1.0000
12:121669335:TCAC:Tdonor_loss1.0000
12:121669336:CAC:Cdonor_loss1.0000
12:121669337:A:ACdonor_gain1.0000
12:121669337:A:AGdonor_loss1.0000
12:121669338:C:Adonor_loss1.0000
12:121669338:C:CCdonor_gain1.0000
12:121669338:CCGT:Cdonor_gain1.0000
12:121652754:T:TAdonor_gain0.9900
12:121652808:CCTG:Cacceptor_loss0.9900
12:121653102:AGGGG:Adonor_gain0.9900
12:121654265:GGCAC:Gdonor_loss0.9900
12:121654266:GCACT:Gdonor_loss0.9900
12:121654268:ACTCA:Adonor_loss0.9900
12:121654272:ACT:Adonor_gain0.9900
12:121654273:CTC:Cdonor_gain0.9900
12:121654273:CTCA:Cdonor_gain0.9900
12:121654273:CTCAG:Cdonor_gain0.9900
12:121654292:C:CAdonor_gain0.9900
12:121654293:C:Adonor_gain0.9900
12:121654429:TAACC:Tacceptor_gain0.9900
12:121654432:CC:Cacceptor_gain0.9900

AlphaMissense

1597 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:121654316:A:GW141R0.978
12:121654316:A:TW141R0.978
12:121654354:C:GR128P0.978
12:121653247:C:GR159P0.970
12:121659211:A:GW95R0.961
12:121659211:A:TW95R0.961
12:121653161:A:GW188R0.960
12:121653161:A:TW188R0.960
12:121669360:A:GW42R0.954
12:121669360:A:TW42R0.954
12:121654321:C:TG139E0.945
12:121654357:C:TG127D0.942
12:121659270:C:TG75D0.942
12:121654314:C:AW141C0.941
12:121654314:C:GW141C0.941
12:121654427:C:AG104W0.940
12:121659209:C:AW95C0.940
12:121659209:C:GW95C0.940
12:121659304:C:AG64W0.940
12:121653233:A:GW164R0.939
12:121653233:A:TW164R0.939
12:121654391:C:GG116R0.939
12:121659298:A:GW66R0.939
12:121659298:A:TW66R0.939
12:121654322:C:GG139R0.938
12:121654322:C:TG139R0.938
12:121653239:C:GG162R0.935
12:121653175:A:GL183P0.933
12:121654315:C:GW141S0.932
12:121654426:C:TG104E0.932

dbSNP variants (sampled 300 via entrez): RS1000121670 (12:121652093 G>A), RS1000124103 (12:121670041 T>C), RS1000136023 (12:121662580 C>A,G,T), RS1000178381 (12:121665747 A>C), RS1000230726 (12:121665393 C>G), RS1000246464 (12:121668689 G>A), RS1000250885 (12:121668402 G>A,C), RS1000359393 (12:121659482 C>T), RS1000440800 (12:121674148 G>A), RS1000519226 (12:121667252 G>A), RS1000581056 (12:121660840 G>C,T), RS1000904295 (12:121651418 C>T), RS1000970157 (12:121658358 G>A,C), RS1001129430 (12:121661395 A>G), RS1001247467 (12:121667762 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
Air Pollutantsdecreases expression, increases abundance, increases expression2
Estradiolaffects cotreatment, decreases expression2
Valproic Acidaffects cotreatment, increases expression2
aristolochic acid Iincreases expression1
sotorasibaffects cotreatment, decreases expression1
triphenyl phosphateaffects expression1
bisphenol Adecreases methylation1
S-(1,2-dichlorovinyl)cysteineincreases expression1
CGP 52608affects binding, increases reaction1
2-palmitoylglycerolincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
dorsomorphinincreases expression, affects cotreatment1
trametinibaffects cotreatment, decreases expression1
NVP-BKM120affects cotreatment, decreases expression1
theaflavin-3,3’-digallateaffects expression1
Arsenicaffects methylation1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1increases methylation1
Genisteinincreases expression1
S-Nitrosoglutathioneincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.